Cargando…
Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration
Autores principales: | Chatzidionysiou, Katerina, Lie, Elisabeth, Nasonov, Evgeny, Lukina, Galina, Hetland, Merete Lund, Tarp, Ulrik, Ancuta, Ioan, Pavelka, Karel, Nordström, Dan C., Gabay, Cem, Canhão, Helene, Tomsic, Matija, van Riel, Piet L. C. M., Gomez-Reino, Juan, Kvien, Tore K., van Vollenhoven, Ronald F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915078/ https://www.ncbi.nlm.nih.gov/pubmed/27324256 http://dx.doi.org/10.1186/s13075-016-1048-4 |
Ejemplares similares
-
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration
por: Chatzidionysiou, Katerina, et al.
Publicado: (2016) -
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study
por: Gabay, Cem, et al.
Publicado: (2016) -
Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries
por: Lauper, Kim, et al.
Publicado: (2018) -
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2011) -
Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study
por: Kastbom, Alf, et al.
Publicado: (2012)